Search clinical trials for: Anti-OX40

Total 87277 results

Technische Universität Dresden
University Hospital Carl Gustav Carus; Cellex Gesellschaft für Zellgewinnung... and other collaborators

Completed

Plerixafor as a Salvage Regimen to Mobilize Allogeneic Stem Cells in Healthy Volunteers (MOBIL1)

Blood Stem Cell Harvest Failure

Germany
Boehringer Ingelheim

Completed

Pharmaco-epidemiological Description of the Population Treated With Aptivus Under Market Conditions, Safety & Efficacy

HIV Infections

France
Sarawak MediChem Pharmaceuticals

Unknown

The Safety and Effectiveness of (+)-Calanolide A in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

HIV Infections

United States
University of California, San Francisco

Completed

A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease

HIV Infections | Mycobacterium Avium-intracellulare Infection

United States
Peking University Third Hospital

Recruiting

Effect of Postvitrectomy Proactive Use of Conbercept on Postoperative Complications in PDR Patients

Proliferative Diabetic Retinopathy

China
Proclara Biosciences, Inc.
Alzheimer's Association

Completed

Multiple Dose Safety Study of NPT088 in Patients With Mild to Moderate Probable Alzheimer's Disease

Alzheimer Disease

United States
National Institute of Allergy and Infectious Diseases...

Completed

Comparing the Efficacy and Safety of High-Titer Versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A

Influenza A Virus Infection

United States
Sohag University

Recruiting

(Anti-Ribosomal P Protein,Anti-U1 RNP, Anti-Nucleosome and Anti-ds DNA Antibodies) and Relation to Depression and Anxiety in SLE

Systemic Lupus Erythematosus

Egypt
National Cancer Center, Korea

Completed

Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients

Early Gastric Cancer | Tuberculosis | Tuberculosis, Pulmonary

Korea, Republic of
Affiliated Hospital to Academy of Military Medical...

Unknown

Anti-CD22 CAR-T Cell Therapy Targeting B Cell Malignancies

Lymphoma | Leukemia

China
National Institute of Allergy and Infectious Diseases...

Recruiting

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

Infections | Warts | Neutropenia | Leukopenia | Myelokathexis

United States
Ensoma
bluebird bio

Terminated

Study of MGTA-145 and Plerixafor in Patients With Sickle Cell Disease

Sickle Cell Disease

United States
Radboud University Medical Center

Completed

Pharmacokinetic Study With a Loading Dose of Clofazimine in Adult Patients With Nontuberculous Mycobacterial Disease (C-LOAD)

Nontuberculous Mycobacterial Diseases

Netherlands
National Institute of Allergy and Infectious Diseases...

Completed

Pharmacokinetic Study of Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults

HIV Infections

United States
Hospital Universitari Vall d'Hebron Research Institute
CIEMAT; CIBERER

Completed

Clinical Phase II Trial to Evaluate CD34+ Cells Mobilization and Collection in Patients With Fanconi Anemia for Subsequent Transduction With a Lentiviral Vector Carring FANCA Gene. FANCOSTEM-1

Fanconi Anemia

Spain
Polyphor Ltd.

Terminated

Pivotal Study in Nosocomial Pneumonia Suspected or Confirmed to be Due to Pseudomonas (PRISM-UDR)

Pneumonia

United States, Israel, France, Czechia
Children's Hospital of The King's Daughters
Novartis; Genentech, Inc.

Completed

A Description of Inflammatory Cell Types In Moderate to Severe Pediatric Asthma: Eosinophilic and Non Eosinophilic Sputum Markers While on Anti-IgE Therapy

ALLERGIC ASTHMA
Tufts Medical Center

Terminated

Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation

Lymphoma | Multiple Myeloma | Chronic Lymphocytic Leukemia

United States
University of Minnesota
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Tissue Drug Levels of HIV Medications

Human Immunodeficiency Virus

United States
Genzyme, a Sanofi Company

Completed

A Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM (Multiple Myeloma). (PREDICT)

Transplantation | Lymphoma (Non-Hodgkin's Lymphoma) | Hodgkin's Disease or Multiple Myeloma | Front Line Mobilization

Netherlands, France, Germany, Sweden, Spain, Italy, United Kingdom
Genzyme, a Sanofi Company

Completed

A Phase I Dose Escalation Study of Plerixafor in Healthy Subjects of Japanese Descent

Healthy Volunteer

United States
Santen Pharmaceutical(China) Co.,LTD

Completed

A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Syndrome

Dry Eye Syndromes | Sjögren Syndrome

China
Johns Hopkins University
National Institute of Allergy and Infectious Diseases (NIAID); Genentech, Inc.

Completed

The Effects of Omalizumab (Anti-IgE) on the Late-phase Response to Nasal Allergen Challenge

Cat Allergy

United States
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Prospective Observational Study on Plerixafor After Chemotherapy

Lymphoma | Myeloma

Italy
Almirall, S.A.

Completed

Efficacy and Safety of LAS41003 in the Treatment of Intertriginous Candida Infections

Candidiasis

Germany
International Partnership for Microbicides, Inc.

Withdrawn

A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa

HIV Infections

South Africa, Malawi, Rwanda, Zimbabwe
Shi, Patricia, M.D.
Genzyme, a Sanofi Company

Unknown

Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection

Multiple Myeloma | Non-Hodgkins Lymphoma

United States
International Partnership for Microbicides, Inc.

Completed

An Expanded Safety Study of Dapivirine Gel 4759 in Africa

HIV Infections | Acquired Immunodeficiency Syndrome

Kenya, Malawi, Rwanda, South Africa, Tanzania
NMP Medical Research Institute

Completed

Homeopathy as an Adjuvant to Chemotherapy Improves Clinical Outcome in Relapsed Pulmonary Tuberculosis

Pulmonary Tuberculosis

India
International Partnership for Microbicides, Inc.

Completed

A Safety Study to Assess the Delivery of Dapivirine From a Matrix Vaginal Ring

HIV Infections

Belgium
Sarawak MediChem Pharmaceuticals

Completed

A Study to Evaluate the Safety and Effectiveness of a New Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), (+)-Calanolide A, in HIV-Positive Patients Who Have Never Received Anti-HIV Treatment

HIV Infections

United States
Hamilton Health Sciences Corporation

Not yet recruiting

Antibiotic Prophylaxis to Prevent Post-procedure UTI After VCUG (APPrUV)

Febrile Urinary Tract Infection | Antibiotic Prophylaxis | Voiding Cystourethrogram
Viriom

Completed

An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers

Covid19 | HIV-1-infection

Russian Federation
University of Minnesota
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Understanding the Increased Risk of Cardiovascular Disease in People With HIV

HIV Infections
Genzyme, a Sanofi Company
Sanofi

Completed

A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone

Neuroblastoma | Brain Tumors | Ewing's Sarcoma/Soft Tissue Sarcoma

Belgium, Czechia, Denmark, France, Germany, Hungary, Israel, Italy, Netherlands, Poland, Spain, United Kingdom
Mitchell Horwitz, MD
Genzyme, a Sanofi Company

Completed

Donor Enhancement With Plerixafor Post Myeloablative Allogeneic Transplant

Failure of Bone Marrow Graft

United States
National Cancer Institute (NCI)

Completed

Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat Melanoma

Skin Cancer | Metastatic Melanoma

United States
López-Medrano, Francisco, M.D.

Completed

Prospective Comparative Study About Treatment of Asymptomatic Bacteriuria in Kidney Transplant Recipients.

Asymptomatic Bacteriuria
University of Padova
Azienda Ospedaliera di Padova

Completed

Stem Cell Mobilization With Plerixafor in Diabetic vs Control Subjects

Diabetes

Italy
University Hospital, Clermont-Ferrand

Completed

Mobilization by Plerixafor of Haematopoietic Stem Cells in Children (MEP1)

Children Cancer, Solid Tumor

France
Emory University

Terminated

AMD3100 for Sensitizing in Allogeneic Blood or Marrow Transplant for Chemotherapy Resistant Pediatric Acute Leukemia (BMTAMD3100)

Pediatric Acute Myeloblastic Leukemia, Relapsed | Pediatric Acute Lymphoblastic Leukemia, Relapsed

United States
Almirall, S.A.

Completed

Efficacy and Safety of LAS41003 in the Treatment of Inflammatory Tinea Pedis

Tinea Pedis

Germany
Autotelicbio

Completed

TASO-001 in Combination With Recombinant Interleukin-2(Aldesleukin) in Advanced or Metastatic Solid Tumor

Solid Tumor

Korea, Republic of
GlaxoSmithKline

Suspended

Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections

Uncomplicated Urinary Tract Infections

United States
St. Jude Children's Research Hospital
Doris Duke Charitable Foundation

Withdrawn

Peripheral Blood Stem Cell Collection From Patients With Sickle Cell Disease (SCD) Using Plerixafor

Sickle Cell Disease

United States
Viriom

Completed

Study of Single Ascending Doses of Elsulfavirine to Evaluate the Safety, Tolerability, and Pharmacokinetics of Elsulfavirine and Its Active Metabolite VM-1500A in Healthy Subjects

HIV-1-infection

United States
Assistance Publique - Hôpitaux de Paris
EuroFancolen

Completed

Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and Plerixafor (FancoMob)

Fanconi Anemia

France
ViiV Healthcare
GlaxoSmithKline

Completed

Study of the Absorption, Metabolism, and Route of Elimination of a Novel Class of Anti-HIV 1 Drugs (BMS-955176) in Humans.

HIV Infections

United States
ViiV Healthcare
GlaxoSmithKline

Completed

Relative Bioavailability Study With BMS-955176

Infection, Human Immunodeficiency Virus

United Kingdom
University of Louisville
Healthpoint

Completed

Comparison of Wound Bed Establishment in Facial Burns

Burns

United States

Search clinical trials for: Anti-OX40

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations